Gastroenterologia y hepatologia
Progression of FIB-4 index predicts major adverse cardiovascular events in patients with metabolic dysfunction.
Francisco Idalsoaga, Verónica Cambindo, Eduardo Fuentes-López, Eitan Dukes, Samuel Ibañez, Paola Hunfan, Constanza Mollo, Jorge Gonzalez, Gustavo Ayares, Carolina Ramirez-Cadiz, Francisco Barrera, Monica Acevedo, Patrick S Kamath, Richard Sterling, Marco Arrese
Published: 202510.1016/j.gastrohep.2025.502608
Abstract
INTRODUCTION: Metabolic dysfunction is highly prevalent worldwide and is associated with metabolic dysfunction-associated steatotic liver disease and an increased risk of cardiovascular disease. However, it remains unclear whether non-invasive tests…
Preview only. Read the full abstract at the source